Back to search

Article

Novel, broad and potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages

2023-11-14

Abstract excerpt

<title>Abstract</title> <p>The continuous emergence of SARS-CoV-2 variants of concern with mutated spike receptor binding domains has rendered many therapeutic mAbs ineffective. To date, there are no clinically authorized therapeutic antibodies effective against the predominant circulating sub-lineages BQ and XBB. Here, we report the isolation of broad and potent neutralizing HuMabs from a Danish healthcare worke...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
542a53d3-e0e0-5b80-a5e1-918b0ecbd49c
DOI
10.21203/rs.3.rs-3062716/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel, broad and potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineagesDOI 10.21203/rs.3.rs-3062716/v1
Select a neighboring publication to make it the new centre.